OLD REPUBLIC INTERNATIONAL CORP (ORI): what the price assumes

In the published model solve dated 2026-Q2, anchored at $43.52, OLD REPUBLIC INTERNATIONAL CORP (ORI) is priced for 12.4% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/ORI

Headline

FieldValue
TickerORI
CompanyOLD REPUBLIC INTERNATIONAL CORP
Current price$43.52/sh
CompositionSpecialty (General) Insurance 65% / Title Insurance 35%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed12.4%
Return on equity now15.8%
ROE gap-3.4pp
Price-to-book1.73x

Solve inputs: computed at a 8.9% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.7pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.57σ
cohort percentile (of 88 peers)49
sustained it ~10 years at this level68%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.87x3justifies
Earnings0.88x1justifies
Relative0
Growth0.99x1justifies

Families that justify the price: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.3%); the inversion above states its own rate.

Per-Model Detail (n=5)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$79.730.55xyesTBVPS $24.66 × 3.23x (ROE (TTM) 18.7% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelativenoP/E 11x (static sector reference · 2026-04), scenarios: 9.1x / 11.0x / 12.9x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowthno
Two-Stage DDMGrowth$44.120.99xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$49.960.87xyesBV/sh $24.66, ROE (TTM) 18.7%, ke 9.3%
Two-Stage Excess ReturnAsset$70.260.62xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $9.7B, growth 12% (input: historical growth; tapered), Terminal P/S: 0.9x / 1.1x / 1.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelativenoEPS $4.56, growth 35% (input: historical EPS growth), PEG=0.27 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$50.300.87xyes√(22.5 × EPS $4.56 × BVPS $24.66) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $4.56 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $4.56 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$49.300.88xyesEPS $4.56 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Specialty (General) Insurancefinancialequity$5.4bwithheldunresolved standalone equity facts required
Title Insurancefinancialequity$2.9bwithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (buyback)-5.1%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Lead with where the earnings have been heading, because the recent trajectory is what makes the price look conservative. Old Republic has been earning a return on equity around 15.8%, yet at $38.70 the market is pricing in a sustained return closer to 11.8% on about 1.6x book. For an insurer, value is read off return on capital and price-to-book rather than an operating multiple, and on that lens the price is asking the company to do less than it has actually been doing. The title segment is the clearest example of momentum: title premiums and fees grew 12% over the prior-year quarter, and title pretax operating income improved to $16.7 million from $4.3 million as the combined ratio in that business moved to 100% from 102% (Old Republic Q1 2026, gurufocus).

The capital-return discipline is real and visible in the filings. The company describes the combined ratio as the metric it manages capital around and ties to incentive compensation: it deploys more capital to grow the segments or less to protect underwriting profitability depending on the ratio (FY2025 10-K, accession 0000074260-26-000008). In the latest quarter that translated into nearly $77 million of dividends and $161 million of buybacks, with $640 million still authorized (Old Republic Q1 2026, gurufocus). The share count has been shrinking at roughly 4.9% a year, which compounds book value per share for the holders who stay.

The peer comparison frames the opportunity. Against a cohort of American Financial, AIG, CNA, Hartford, and W. R. Berkley, Old Republic sits in the lower half of the group's price-to-book despite a competitive return on equity. When the asset, earnings-power, and relative families all sit above the price, the bet is not on a heroic growth story; it is on the company simply continuing to earn what it has earned and keep returning the excess.

Bear Case

The honest bear case is about which assumption in the price is most fragile, and here it is the durability of underwriting profit rather than the headline earnings. The Q1 2026 result flattered the bottom line: net income rose to $330 million, but that was lifted by investment gains. Strip them out and net operating income fell to $170.5 million from $201.7 million, and consolidated pretax operating income dropped to $211.5 million from $252.7 million (Old Republic Q1 2026, stocktitan). The earnings the valuation leans on are the operating ones, and those moved the wrong way.

The combined ratio is the specific number that carries the thesis, and it deteriorated. The consolidated combined ratio rose to 96.6% from 93.7%, and the specialty segment moved to 94.8% from 89.8%. The filings are explicit that the title business is operating into difficult conditions: an elevated combined ratio reflecting difficult market conditions and lower favorable reserve development (FY2025 10-K, accession 0000074260-26-000008). Title premiums track real-estate transaction volume, so if mortgage activity stays subdued the segment's recovery can stall, and reserve development that has been a tailwind can turn into a headwind.

The valuation also depends on the return on equity not fading toward the cost of capital, and the historical base rate is sobering. Only about 70% of firms earning Old Republic's current return sustained it over a roughly ten-year window, and the model's implied return of 11.8% already builds in some fade. The two-stage dividend model that prints $395 is a reminder of how sensitive these book-value models are to the growth assumption; it should be read as a caution about model fragility, not a target.

Valuation

Old Republic is one of the cases where the valuation families line up rather than fight. Because it is an insurer, the operating-multiple models are set aside and the read comes off return on capital and price-to-book. The asset and earnings families agree directionally: Two-Stage Excess Return at $60, Simple Excess Return at $44, Graham Number at $47, Earnings Yield at $44, and Relative Valuation at $51 on a sector P/E near 11x. None of the credible methods sits below the $38.70 price.

Inverting the price says the market is underwriting a sustained return on equity of about 11.8% at roughly 1.6x book, computed at an 8.9% cost of equity with 4% terminal growth, where each point of cost of equity moves the implied return about 1.6 points. For reference the company has recently earned about 15.8%, so the price is assuming a meaningful fade. The overall priced-in assumption reads as within range, which is the right characterization: this is a value-and-asset-supported name where the price is broadly consistent with plausible returns and arguably conservative if underwriting stabilizes. Treat the outlier dividend-model figure as model noise; it is hypersensitive to the stage-one growth input and not a serious estimate of value.

Catalysts

Old Republic reported Q1 2026 results on April 23, 2026. Net income was $330.0 million, up from $245.0 million, but the gain was driven by investment results: net operating income fell to $170.5 million from $201.7 million, consolidated pretax operating income dropped to $211.5 million, and the consolidated combined ratio rose to 96.6% from 93.7% (Old Republic Q1 2026 transcript, Motley Fool). Within the segments, specialty insurance ran a 94.8% combined ratio (from 89.8%) while title improved to 100% from 102% with premiums and fees up 12% and pretax operating income of $16.7 million (gurufocus).

The forward watch items are underwriting trend and capital return rather than any single event. The company paid nearly $77 million in dividends and repurchased $161 million of stock in the quarter, leaving $640 million on the buyback authorization, so the pace of repurchases is a direct catalyst for book-value-per-share growth (gurufocus). The next quarterly print is the test of whether the specialty combined ratio stabilizes and whether title's recovery holds as real-estate transaction volume moves. Reserve development, which the filings flag as having turned less favorable, is the line item that can swing operating earnings in either direction.

Peer Cohorts (Per Segment, With Filing Citations)

Specialty (General) Insurance (reported)

Title Insurance (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive ORI report on boothcheck